成纤维细胞活化蛋白肽靶向近红外 I/II 荧光成像用于肝细胞癌的稳定和功能性检测

IF 8.6 1区 医学 Q1 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING
En Lin, Miaomiao Song, Bo Wang, Xiaojing Shi, Jiali Zhao, Lidan Fu, Zirui Bai, Baojia Zou, Guifang Zeng, Wenfeng Zhuo, Peiping Li, Chaonong Cai, Zhen Cheng, Zhenhua Hu, Jian Li
{"title":"成纤维细胞活化蛋白肽靶向近红外 I/II 荧光成像用于肝细胞癌的稳定和功能性检测","authors":"En Lin, Miaomiao Song, Bo Wang, Xiaojing Shi, Jiali Zhao, Lidan Fu, Zirui Bai, Baojia Zou, Guifang Zeng, Wenfeng Zhuo, Peiping Li, Chaonong Cai, Zhen Cheng, Zhenhua Hu, Jian Li","doi":"10.1007/s00259-025-07093-6","DOIUrl":null,"url":null,"abstract":"<h3 data-test=\"abstract-sub-heading\">Purpose</h3><p>Cancer-associated fibroblasts (CAFs) are the primary stromal component of the tumor microenvironment in hepatocellular carcinoma (HCC), affecting tumor progression and post-resection recurrence. Fibroblast activation protein (FAP) is a key biomarker of CAFs. However, there is limited evidence on using FAP as a target in near-infrared (NIR) fluorescence imaging for HCC. Thus, this study aims to develop a novel NIR fluorescent imaging strategy targeting FAP<sup>+</sup> CAFs in HCC.</p><h3 data-test=\"abstract-sub-heading\">Methods</h3><p>The ICG-FAP-TATA probe was synthesized by conjugating a novel cyclization anti-FAP peptide with an indocyanine green derivative (ICG-NH<sub>2</sub>) as fluorophore, capable for NIR window I (NIR-I, 700–900 nm) and II (NIR-II, 1000–1700 nm) imaging. Its efficacy in lesion localization and other potential applications was evaluated.</p><h3 data-test=\"abstract-sub-heading\">Results</h3><p>In vivo imaging of subcutaneous HCC models revealed that ICG-FAP-TATA specifically targeted FAP<sup>+</sup> CAFs in the stroma and detected differences in CAFs loading within lesions. The fluorescence intensity/tumor-to-background ratio (TBR) positively correlated with FAP expression (R<sup>2</sup> &gt; 0.8,<i> p</i> &lt; 0.05). Ex vivo incubation of tumor tissues with ICG-FAP-TATA provided stable fluorescence imaging of tumors in subcutaneous and orthotopic HCC models, including different cell line co-culture systems (LM3-luc, MHCC97H-luc, HepG2-luc + LX2), and various liver backgrounds (healthy/fibrotic) (n = 5 per group). TBR of the tumor mice models was higher for NIR-II than NIR-I imaging (3.89 ± 1.27 <i>vs.</i> 2.64 ± 0.64, <i>p</i> &lt; 0.05). Moreover, NIR-I/II imaging of fresh tissues from seven patients with HCC undergoing surgery incubated with ICG-FAP-TATA visually provided the spatial distribution heterogeneity of CAFs. The targeted fluorescence was relatively enriched more in the blood flow direction and at the tumor edge, both of which were associated with tumor metastasis (all<i> p</i> &lt; 0.05).</p><h3 data-test=\"abstract-sub-heading\">Conclusion</h3><p>This study presents a rapid and effective method for detecting HCC lesions, locating FAP<sup>+</sup> CAFs, and visualizing high-risk areas for tumor metastasis at the macroscopic level. It offers a new promising approach with translational potential for imaging HCC.</p>","PeriodicalId":11909,"journal":{"name":"European Journal of Nuclear Medicine and Molecular Imaging","volume":"31 1","pages":""},"PeriodicalIF":8.6000,"publicationDate":"2025-01-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Fibroblast activation protein peptide-targeted NIR-I/II fluorescence imaging for stable and functional detection of hepatocellular carcinoma\",\"authors\":\"En Lin, Miaomiao Song, Bo Wang, Xiaojing Shi, Jiali Zhao, Lidan Fu, Zirui Bai, Baojia Zou, Guifang Zeng, Wenfeng Zhuo, Peiping Li, Chaonong Cai, Zhen Cheng, Zhenhua Hu, Jian Li\",\"doi\":\"10.1007/s00259-025-07093-6\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<h3 data-test=\\\"abstract-sub-heading\\\">Purpose</h3><p>Cancer-associated fibroblasts (CAFs) are the primary stromal component of the tumor microenvironment in hepatocellular carcinoma (HCC), affecting tumor progression and post-resection recurrence. Fibroblast activation protein (FAP) is a key biomarker of CAFs. However, there is limited evidence on using FAP as a target in near-infrared (NIR) fluorescence imaging for HCC. Thus, this study aims to develop a novel NIR fluorescent imaging strategy targeting FAP<sup>+</sup> CAFs in HCC.</p><h3 data-test=\\\"abstract-sub-heading\\\">Methods</h3><p>The ICG-FAP-TATA probe was synthesized by conjugating a novel cyclization anti-FAP peptide with an indocyanine green derivative (ICG-NH<sub>2</sub>) as fluorophore, capable for NIR window I (NIR-I, 700–900 nm) and II (NIR-II, 1000–1700 nm) imaging. Its efficacy in lesion localization and other potential applications was evaluated.</p><h3 data-test=\\\"abstract-sub-heading\\\">Results</h3><p>In vivo imaging of subcutaneous HCC models revealed that ICG-FAP-TATA specifically targeted FAP<sup>+</sup> CAFs in the stroma and detected differences in CAFs loading within lesions. The fluorescence intensity/tumor-to-background ratio (TBR) positively correlated with FAP expression (R<sup>2</sup> &gt; 0.8,<i> p</i> &lt; 0.05). Ex vivo incubation of tumor tissues with ICG-FAP-TATA provided stable fluorescence imaging of tumors in subcutaneous and orthotopic HCC models, including different cell line co-culture systems (LM3-luc, MHCC97H-luc, HepG2-luc + LX2), and various liver backgrounds (healthy/fibrotic) (n = 5 per group). TBR of the tumor mice models was higher for NIR-II than NIR-I imaging (3.89 ± 1.27 <i>vs.</i> 2.64 ± 0.64, <i>p</i> &lt; 0.05). Moreover, NIR-I/II imaging of fresh tissues from seven patients with HCC undergoing surgery incubated with ICG-FAP-TATA visually provided the spatial distribution heterogeneity of CAFs. The targeted fluorescence was relatively enriched more in the blood flow direction and at the tumor edge, both of which were associated with tumor metastasis (all<i> p</i> &lt; 0.05).</p><h3 data-test=\\\"abstract-sub-heading\\\">Conclusion</h3><p>This study presents a rapid and effective method for detecting HCC lesions, locating FAP<sup>+</sup> CAFs, and visualizing high-risk areas for tumor metastasis at the macroscopic level. It offers a new promising approach with translational potential for imaging HCC.</p>\",\"PeriodicalId\":11909,\"journal\":{\"name\":\"European Journal of Nuclear Medicine and Molecular Imaging\",\"volume\":\"31 1\",\"pages\":\"\"},\"PeriodicalIF\":8.6000,\"publicationDate\":\"2025-01-21\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"European Journal of Nuclear Medicine and Molecular Imaging\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1007/s00259-025-07093-6\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Nuclear Medicine and Molecular Imaging","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s00259-025-07093-6","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING","Score":null,"Total":0}
引用次数: 0

摘要

癌相关成纤维细胞(CAFs)是肝细胞癌(HCC)肿瘤微环境的主要基质成分,影响肿瘤进展和切除后复发。成纤维细胞活化蛋白(FAP)是CAFs的关键生物标志物。然而,使用FAP作为肝癌近红外(NIR)荧光成像靶点的证据有限。因此,本研究旨在开发一种针对肝癌FAP+ CAFs的新型近红外荧光成像策略。方法将一种新型环化抗fap肽与吲哚菁绿衍生物(ICG-NH2)偶联合成ICG-FAP-TATA探针,具有近红外窗口I (NIR-I, 700 ~ 900 nm)和II (NIR-II, 1000 ~ 1700 nm)成像功能。评价了其在病灶定位方面的疗效及其他潜在应用。结果皮下HCC模型的体内成像显示,ICG-FAP-TATA特异性靶向间质中FAP+ CAFs,并检测到病变内CAFs负荷的差异。荧光强度/肿瘤与背景比(TBR)与FAP表达呈正相关(R2 > 0.8, p < 0.05)。用ICG-FAP-TATA体外培养肿瘤组织,可在皮下和原位肝癌模型中提供稳定的肿瘤荧光成像,包括不同细胞系共培养系统(LM3-luc、MHCC97H-luc、HepG2-luc + LX2)和不同肝脏背景(健康/纤维化)(每组n = 5)。NIR-II成像的肿瘤小鼠模型TBR高于NIR-I成像(3.89±1.27比2.64±0.64,p < 0.05)。此外,对7例接受手术的HCC患者的新鲜组织进行ir - i /II成像,用ICG-FAP-TATA孵育,从视觉上提供了CAFs的空间分布异质性。血流方向和肿瘤边缘的靶向荧光相对更富集,两者与肿瘤转移相关(p < 0.05)。结论本研究提供了一种在宏观水平上快速有效地检测HCC病变、定位FAP+ CAFs、可视化肿瘤转移高危区域的方法。它为HCC成像提供了一种具有翻译潜力的新方法。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Fibroblast activation protein peptide-targeted NIR-I/II fluorescence imaging for stable and functional detection of hepatocellular carcinoma

Purpose

Cancer-associated fibroblasts (CAFs) are the primary stromal component of the tumor microenvironment in hepatocellular carcinoma (HCC), affecting tumor progression and post-resection recurrence. Fibroblast activation protein (FAP) is a key biomarker of CAFs. However, there is limited evidence on using FAP as a target in near-infrared (NIR) fluorescence imaging for HCC. Thus, this study aims to develop a novel NIR fluorescent imaging strategy targeting FAP+ CAFs in HCC.

Methods

The ICG-FAP-TATA probe was synthesized by conjugating a novel cyclization anti-FAP peptide with an indocyanine green derivative (ICG-NH2) as fluorophore, capable for NIR window I (NIR-I, 700–900 nm) and II (NIR-II, 1000–1700 nm) imaging. Its efficacy in lesion localization and other potential applications was evaluated.

Results

In vivo imaging of subcutaneous HCC models revealed that ICG-FAP-TATA specifically targeted FAP+ CAFs in the stroma and detected differences in CAFs loading within lesions. The fluorescence intensity/tumor-to-background ratio (TBR) positively correlated with FAP expression (R2 > 0.8, p < 0.05). Ex vivo incubation of tumor tissues with ICG-FAP-TATA provided stable fluorescence imaging of tumors in subcutaneous and orthotopic HCC models, including different cell line co-culture systems (LM3-luc, MHCC97H-luc, HepG2-luc + LX2), and various liver backgrounds (healthy/fibrotic) (n = 5 per group). TBR of the tumor mice models was higher for NIR-II than NIR-I imaging (3.89 ± 1.27 vs. 2.64 ± 0.64, p < 0.05). Moreover, NIR-I/II imaging of fresh tissues from seven patients with HCC undergoing surgery incubated with ICG-FAP-TATA visually provided the spatial distribution heterogeneity of CAFs. The targeted fluorescence was relatively enriched more in the blood flow direction and at the tumor edge, both of which were associated with tumor metastasis (all p < 0.05).

Conclusion

This study presents a rapid and effective method for detecting HCC lesions, locating FAP+ CAFs, and visualizing high-risk areas for tumor metastasis at the macroscopic level. It offers a new promising approach with translational potential for imaging HCC.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
15.60
自引率
9.90%
发文量
392
审稿时长
3 months
期刊介绍: The European Journal of Nuclear Medicine and Molecular Imaging serves as a platform for the exchange of clinical and scientific information within nuclear medicine and related professions. It welcomes international submissions from professionals involved in the functional, metabolic, and molecular investigation of diseases. The journal's coverage spans physics, dosimetry, radiation biology, radiochemistry, and pharmacy, providing high-quality peer review by experts in the field. Known for highly cited and downloaded articles, it ensures global visibility for research work and is part of the EJNMMI journal family.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信